We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+37.69%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$7.48B
AUM Growth
+$1.44B
Cap. Flow
-$77.6M
Cap. Flow %
-1.04%
Top 10 Hldgs %
23.83%
Holding
336
New
58
Increased
161
Reduced
69
Closed
35

Top Buys

Rank Stock Value
1
AVLN
Avalyn Pharma
AVLN
+$39.7M
2
CDNS icon
Cadence Design Systems
CDNS
+$29.6M
3
RELY icon
Remitly
RELY
+$27.3M
4
DELL icon
Dell
DELL
+$25.5M
5
FITB
Fifth Third Bancorp
FITB
+$25.3M

Top Sells

Rank Stock Value
1
XMTR icon
Xometry
XMTR
+$57.8M
2
PLD icon
Prologis
PLD
+$56.1M
3
GH icon
Guardant Health
GH
+$44M
4
AXSM icon
Axsome Therapeutics
AXSM
+$44M
5
GLBE icon
Global E Online
GLBE
+$37.6M

Sector Composition

Rank Sector Weight
1 Healthcare 36.37%
2 Technology 22.57%
3 Industrials 20.48%
4 Energy 5.51%
5 Utilities 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WTW icon
126
Willis Towers Watson
WTW
$32B
$15.9M 0.21%
60,725
-2,388
-4% -$639K
NXPI icon
127
NXP Semiconductors
NXPI
$56B
$15.8M 0.21%
+56,232
New +$15.5M
AMD icon
128
Advanced Micro Devices
AMD
$769B
$15M 0.2%
26,328
+9,802
+59% +$4.02M
FANG icon
129
Diamondback Energy
FANG
$55.5B
$15M 0.2%
84,257
+16,348
+24% +$3.17M
HD icon
130
Home Depot
HD
$327B
$14.9M 0.2%
42,396
+8,209
+24% +$2.67M
UTHR icon
131
United Therapeutics
UTHR
$22.2B
$14.7M 0.2%
27,101
-1,451
-5% -$817K
ACHV icon
132
Achieve Life Sciences
ACHV
$832M
$14.5M 0.19%
+2,220,000
New +$10.6M
CIEN icon
133
Ciena
CIEN
$53.7B
$14.5M 0.19%
29,559
+25,548
+637% +$13M
CAT icon
134
Caterpillar
CAT
$368B
$13.8M 0.18%
13,306
+1,507
+13% +$1.32M
AMGN icon
135
Amgen
AMGN
$233B
$13.8M 0.18%
38,166
+9,519
+33% +$3.26M
KLRA
136
Kailera Therapeutics
KLRA
$2.24B
$13.6M 0.18%
+616,720
New +$13.6M
PNR icon
137
Pentair
PNR
$9.75B
$13.6M 0.18%
177,107
-82,488
-32% -$6.53M
XYL icon
138
Xylem
XYL
$25.8B
$13.5M 0.18%
113,944
+509
+0.4% +$58.8K
PRAX icon
139
Praxis Precision Medicines
PRAX
$9.75B
$13M 0.17%
38,684
+44
+0.1% +$13.9K
RLMD icon
140
Relmada Therapeutics
RLMD
$467M
$12.9M 0.17%
1,858,416
+1,016,310
+121% +$7.1M
HAL icon
141
Halliburton
HAL
$30.2B
$12.8M 0.17%
375,474
-193,072
-34% -$7.54M
LAD icon
142
Lithia Motors
LAD
$8.17B
$12.7M 0.17%
43,813
+1,245
+3% +$354K
LITE icon
143
Lumentum
LITE
$80.7B
$12.6M 0.17%
14,672
-199
-1% -$178K
TNGX icon
144
Tango Therapeutics
TNGX
$4.04B
$12.5M 0.17%
+400,000
New +$9.89M
LIN icon
145
Linde
LIN
$225B
$11.6M 0.16%
22,433
+1,781
+9% +$902K
TTAN
146
ServiceTitan Inc
TTAN
$9.4B
$11.5M 0.15%
162,882
+61
+0% +$3.93K
XOM icon
147
ExxonMobil
XOM
$642B
$11.3M 0.15%
83,010
+19,516
+31% +$2.92M
MDT icon
148
Medtronic
MDT
$117B
$11.1M 0.15%
138,227
+24,493
+22% +$1.98M
GPI icon
149
Group 1 Automotive
GPI
$3.16B
$11M 0.15%
37,770
-5,067
-12% -$1.66M
IP icon
150
International Paper
IP
$20.8B
$10.8M 0.15%
284,624
-360,814
-56% -$12.4M
4 5
6
7 8

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Eventide Asset Management held 336 positions worth $7.48B, up 24% from $6.05B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q2 2026 filing shows 58 new, 161 increased, 69 reduced and 35 closed positions. Its largest new stake was Avalyn Pharma: 1,375,486 shares worth $45.3M. The largest sale was Xometry, an estimated $57.8M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q2 2026 buy was Avalyn Pharma: 1,375,486 shares worth $45.3M.
  • Eventide Asset Management added most to Cadence Design Systems in Q2 2026, an estimated $29.6M increase.
  • Eventide Asset Management's biggest Q2 2026 reduction was Xometry, cutting an estimated $57.8M.
  • Eventide Asset Management fully exited Prologis in Q2 2026, selling an estimated $56.1M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $7.48B portfolio in Q2 2026.
  • Eventide Asset Management opened 58 new positions and closed 35 in Q2 2026.
  • Eventide Asset Management's portfolio value rose 24% quarter-over-quarter to $7.48B.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.